Cardiac Magnetic Resonance Postcontrast T1 Time Is Associated With Outcome in Patients With Heart Failure and Preserved Ejection Fraction - Wikidata - wikimedia - TriplyDB

Cardiac Magnetic Resonance Postcontrast T1 Time Is Associated With Outcome in Patients With Heart Failure and Preserved Ejection Fraction

Cardiac Magnetic Resonance Postcontrast T1 Time Is Associated With Outcome in Patients With Heart Failure and Preserved Ejection Fraction

http://www.wikidata.org/entity/Q58070990

about

Introduction to Cardiovascular Magnetic Resonance: Technical Principles and Clinical Applications The role of titin and extracellular matrix remodelling in heart failure with preserved ejection fraction Understanding heart failure with preserved ejection fraction: where are we today?Left ventricular function assessment in cirrhosis: Current methods and future directions.Increased extracellular volume and altered mechanics are associated with LVH in hypertensive heart disease, not hypertension alone.Myocardial Regional Interstitial Fibrosis is Associated With Left Intra-Ventricular Dyssynchrony in Patients With Heart Failure: A Cardiovascular Magnetic Resonance Study.Cardiac magnetic resonance assessment of interstitial myocardial fibrosis and cardiomyocyte hypertrophy in hypertensive mice treated with spironolactone.Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study.Outcome in Heart Failure with Preserved Ejection Fraction: The Role of Myocardial Structure and Right Ventricular Performance Pulmonary artery to aorta ratio for the detection of pulmonary hypertension: cardiovascular magnetic resonance and invasive hemodynamics in heart failure with preserved ejection fraction Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.Histologic validation of myocardial fibrosis measured by T1 mapping: a systematic review and meta-analysis.Gadolinium free cardiovascular magnetic resonance with 2-point Cine balanced steady state free precession.Presence of ´isolated´ tricuspid regurgitation should prompt the suspicion of heart failure with preserved ejection fraction Cardiac MRI: a central prognostic tool in myocardial fibrosis.T1 mapping: non-invasive evaluation of myocardial tissue composition by cardiovascular magnetic resonance.The (dys)functional extracellular matrix.PET/MR: Yet another Tesla?Right ventricular dysfunction in heart failure with preserved ejection fraction: a systematic review and meta-analysis.Electrocardiographic Impact of Myocardial Diffuse Fibrosis and Scar: MESA (Multi-Ethnic Study of Atherosclerosis).Soluble neprilysin does not correlate with outcome in heart failure with preserved ejection fraction.Novel plasma and imaging biomarkers in heart failure with preserved ejection fraction.Myocardial Native T1 Time in Patients With Hypertrophic Cardiomyopathy.Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T.Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Seeing the unseen fibrosis in heart failure with preserved ejection fraction.Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis.Systemic inflammation is associated with myocardial fibrosis, diastolic dysfunction, and cardiac hypertrophy in patients with hypertrophic cardiomyopathy.Comparison of MOLLI, shMOLLLI, and SASHA in discrimination between health and disease and relationship with histologically derived collagen volume fraction.Extracellular volume quantification by cardiac magnetic resonance imaging without hematocrit sampling : Ready for prime time?Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction.Wedge Pressure Rather Than Left Ventricular End-Diastolic Pressure Predicts Outcome in Heart Failure With Preserved Ejection Fraction.Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology.The evaluation of non-ischemic dilated cardiomyopathy with T1 mapping and ECV methods using 3T cardiac MRI.Diffuse myocardial fibrosis among healthy pediatric heart transplant recipients: Correlation of histology, cardiovascular magnetic resonance, and clinical phenotype.Impact of atrial fibrillation on rest and exercise haemodynamics in heart failure with mid-range and preserved ejection fraction.The Emerging Role of Cardiac Magnetic Resonance Imaging in the Evaluation of Patients with HFpEF.Cardiac extracellular matrix is associated with adverse outcome in patients with chronic heart failure.Impact of Systemic Volume Status on Cardiac Magnetic Resonance T1 Mapping.

P2860

Q26749269-DC5D8950-E387-486F-9918-4A859A8C38BB Q26765101-2E1C265D-C959-46C4-A9B2-564EDA9805E2 Q26766590-43DFC33F-B53D-457F-A487-2DF8ECE44DA9 Q26769598-D5C96A1E-DE03-4F38-8A2F-460C8D489E95 Q30300980-FE1999FA-E64F-49E8-A565-FF962CCFA402 Q30391425-50183146-0EA7-4CF5-9199-DE147A6EB577 Q30833375-0B19290D-9A1E-47D8-801D-A24CC3C3241A Q34374909-DEF75C75-4056-49B5-9862-D9C1FCA22FAD Q35725839-32D1DB1C-147E-41D4-B3D4-529C69AAED93 Q36006309-30F52FBD-ED93-4F2A-97D8-E0F8D49A0405 Q36088154-2CE500DB-B2E7-4FAF-BC24-7CAB15FD0B0A Q36220925-BAA146F3-E500-4077-BA50-B2B7C270DF87 Q36235217-A0EF4EAF-F7EF-4017-A9AD-66BE242BC407 Q36281115-862636B4-13D0-4D34-96E8-6215DCB953BC Q38263089-9B35B2C6-759C-4DBB-8501-E1F2076BE542 Q38270769-314A5B29-571F-42C7-88B3-23DCCD35EE23 Q38452473-9F1FCE1B-BA78-4F1A-9693-B0DB8C2A12CC Q38818563-D506734C-FCF1-41AA-B60A-A434561F9938 Q38959952-D47A7301-AD13-46B6-889C-8F5327EFD01B Q38980504-58B46963-7499-493E-A7F8-0229B9219814 Q40149965-2186C1B3-911E-4BD8-8EDC-FBC05E8A0901 Q40963394-93A73560-3794-47C0-96D6-BB85F11DE4F6 Q41629593-0473A653-1810-4F3E-9296-F59C0632B0E5 Q42089705-99784637-77A1-4CE1-82AB-94F82CF7AF54 Q42373017-E12FB3CE-5859-419B-A476-BFE9AE8F4B86 Q42560934-DD27C55A-877A-4767-B0DA-2B205024C768 Q45921977-4B663426-C2C1-464E-841D-FA3989C1DCC5 Q47152878-19BA65E2-1153-4497-85FC-CA6C6FC6642D Q47297387-16BFCD90-9F39-4F7A-85CC-3AFAF3EDA67A Q47619369-179D5E9D-32C8-482F-82A5-E4A95E173872 Q47755913-86BE6A95-F2A0-43E1-A25F-F8CBE7C14455 Q47794661-DB37EEA3-0556-4F9D-9B4A-D031CFAD492A Q47890686-C476B71B-9C2D-4E7C-82C1-26A9A5DA9D42 Q48271337-7A6D9807-FEEA-4F5F-92D4-939E0E569BF6 Q48337289-D54505C8-D648-445D-8068-0CCF9E17E751 Q50099011-154CEF6F-2DF1-4112-866F-77A2556243C1 Q50193228-5400DA4C-5FB2-4B4F-B3CD-3482C8FEEFA0 Q52819862-9158F2AC-4609-4701-A391-CDBB6ADC2CF0 Q55494001-D08E2519-C309-4C13-B22C-9476C1E4DAFA

P2860

Cardiac Magnetic Resonance Postcontrast T1 Time Is Associated With Outcome in Patients With Heart Failure and Preserved Ejection Fraction

http://www.wikidata.org/entity/Q58070990

description

im November 2013 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 13 September 2013

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2013

@uk

name

Cardiac Magnetic Resonance Pos ...... nd Preserved Ejection Fraction

@en

Cardiac Magnetic Resonance Pos ...... nd Preserved Ejection Fraction

@nl

type

label

Cardiac Magnetic Resonance Pos ...... nd Preserved Ejection Fraction

@en

Cardiac Magnetic Resonance Pos ...... nd Preserved Ejection Fraction

@nl

prefLabel

Cardiac Magnetic Resonance Pos ...... nd Preserved Ejection Fraction

@en

Cardiac Magnetic Resonance Pos ...... nd Preserved Ejection Fraction

@nl

P1433

Q58070990-0480AB6F-BB42-4D18-8542-DB381435B4B2

P1476

Q58070990-87BCF314-8C16-421F-92C1-408FDA3AEB98

P2093

Q58070990-1A39A4C5-26AE-48DA-8E7B-15BA87508DBC

Q58070990-1ABDCCB2-F2DA-4501-8D23-2E66590F572E

Q58070990-38DDA088-8219-41CD-B419-0401A8416985

Q58070990-43AE5A41-24D5-40FD-B460-A706E7CC5606

Q58070990-4C9B0042-ED22-4E75-9A6C-8EBB41D19F13

Q58070990-602562FB-5754-40E8-8172-B49806D7E64D

Q58070990-8451623F-866F-474B-99CD-DA058929BA8D

Q58070990-861C0A64-8043-44D4-91A8-9050F7A57A4E

Q58070990-A2AFECE0-2DEC-4265-A81F-3B93837ED209

Q58070990-B130CD61-56CB-494F-9091-E2A51CD823B1

P304

Q58070990-8E31F621-0FE5-4F4E-BDF3-DBDAE0763EF8

P31

Q58070990-4DFACB78-EDDC-4013-B76F-45F4FF1D6791

P356

Q58070990-D443003E-ED1B-4BC4-8B98-285F707FEA6E

P433

Q58070990-E88AA9EB-53A5-4FBA-8625-04B64D6D7944

P478

Q58070990-49DC808C-1758-4AF9-BCD9-67C60C98536D

P50

Q58070990-1534E3AE-E55A-4EEB-9BF1-2C12E269C0A3

Q58070990-4721D4B8-B841-4267-89A6-09A5690D15CF

Q58070990-884665C9-6C10-4382-8C34-C1752A98A5DF

Q58070990-9C69D03F-75F5-4F8F-8004-4B7B6A05DB2C

Q58070990-BAFF8678-D06C-4AAA-A6F9-BF6AA5EBC8D7

P577

Q58070990-FF02996C-B753-409B-A407-6B04FA33CF68

P698

Q58070990-28414B47-9285-489B-BBDB-A98425761CF8

P921

Q58070990-F86E8680-168F-47B0-8698-5D2A7095CB54

P356

CIRCIMAGING.113.000633

P1433

Circulation: Cardiovascular Imaging

P1476

Cardiac magnetic resonance pos ...... nd preserved ejection fraction

@en

P2093

Adelheid Panzenböck

http://www.w3.org/2001/XMLSchema#string

Beatrice A Marzluf

http://www.w3.org/2001/XMLSchema#string

Caroline Tufaro

http://www.w3.org/2001/XMLSchema#string

Christine Bangert

http://www.w3.org/2001/XMLSchema#string

Daniela Laimer

http://www.w3.org/2001/XMLSchema#string

Diana Bonderman

http://www.w3.org/2001/XMLSchema#string

Gültekin Karakus

http://www.w3.org/2001/XMLSchema#string

Irene M Lang

http://www.w3.org/2001/XMLSchema#string

Martin Hülsmann

http://www.w3.org/2001/XMLSchema#string

Paul Wexberg

http://www.w3.org/2001/XMLSchema#string

P304

1056-1065

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCIMAGING.113.000633

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Johannes Jakowitsch

Catharina Schreiber

Julia Mascherbauer

P577

2013-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24036385

http://www.w3.org/2001/XMLSchema#string

P921